Phase 3 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People under the age of 21 years who have been diagnosed with one of the following conditions: acute lymphoblastic leukemia, myeloblastic leukemia, biphenotypic leukemia, bilinear leukemia, malignant lymphoma, or myelodysplastic syndrome.
Who may not be able to join:
- People aged 21 years or older.
- People with acute lymphoblastic leukemia (ALL) whose disease is not currently in remission (meaning the disease is still active in the blood and body).
- People whose general physical ability and daily functioning scores below a certain level on standard medical rating scales (confirm with trial site).
- People whose heart is not pumping efficiently enough — specifically, where the heart's pumping strength is measured at less than 40% on an ultrasound scan.
- People whose kidneys are not filtering blood well enough, based on a standard kidney function measurement (confirm with trial site).
- People whose liver is not functioning well enough, based on blood test results for liver enzymes and bilirubin being more than twice the normal range.
- People whose lungs are not working well enough — either lung capacity is below 50%, or for children who cannot do a breathing test, blood oxygen levels are below 92%.
- People with an active infection (viral, fungal, or bacterial) that is not under control.
- People, or their caregivers, who have a mental illness that would make it difficult to understand the study or follow the required medical and hygiene instructions.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +79166512145
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
1. Cumulative Incidence stage II-IV after HSCT; Kaplan Meier overal survival; 1. Cumulative Incidence stage II-IV after HSCT; Kaplan Meier event free survival; Kaplan Meier event free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.